Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance
Eur J Pharmacol 570:212221 Veljaca, M, Krnic, Z and Brajsa, K (2002) The development of PL 14736 for treatment of inflammatory bowel disease
Recent studies show a clear gap between clinical trial results and real-world outcomes for GLP-1 agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
Use an insulated cooler or travel case with ice packs if needed
Finally, agent selection is influenced by insurance formulary and cost
Your plan is adjusted using real feedback, not a one-size approach